Key result
Alpha-1 blockers provide effective alternative blood pressure control alongside potentially favorable serum lipid effects.
Answers are grounded in this paper and cite their sources.
Alpha-1 blockers have certain disadvantages over conventional and antihypertensive therapies in their haemodynamic profile and metabolic effects. This paper reviews the development of alpha-blockade, the therapeutic efficacy of prazosin, the prototype alpha-1 blocker, and the rationale for the once-daily antihypertensive compounds, terazosin and doxazosin. These drugs offer a useful alternative to first- or second-line therapy in suitable hypertensive patients, particularly with their potentially beneficial effects on serum lipids.
No takes yet. Share an insight, caveat, or question.
Humphreys et al. (1989) conducted a review in Hypertension. Alpha-1 blockers (prazosin, terazosin, doxazosin) vs. Conventional antihypertensive therapies was evaluated. Alpha-1 blockers (prazosin, terazosin, doxazosin) offer a useful alternative first- or second-line antihypertensive therapy with potentially beneficial effects on serum lipids.
Synapse has enriched 10 related papers. Consider them for comparative context: